5α-Androstanediol is a crucial metabolite in the androgen pathway, formed from dihydrotestosterone (DHT) by the enzyme 3-alpha-hydroxysteroid dehydrogenase (3α-HSD).
This conversion occurs in various tissues including the testes, prostate, liver, brain, skin, muscle, and, in women, the mammary glands and uterus.
As a metabolite of testosterone and DHT, 5α-androstanediol regulates androgenic activity by modulating local DHT levels, influencing sexual development and reproductive functions. This regulation is vital in androgen-sensitive tissues like the prostate, skin, and hair follicles, maintaining a balance between androgenic stimulation and tissue health.
In the prostate, 5α-androstanediol's role in reducing DHT levels can impact conditions like benign prostatic hyperplasia (BPH) and prostate cancer, though alternative androgen production pathways might also affect these outcomes.
Understanding 5α-androstanediol's biochemistry and physiological roles is essential for insights into androgen regulation and its implications for health, particularly in managing hormonal imbalances and androgen-sensitive conditions.
5a-Androstanediol is a metabolite of testosterone and dihydrotestosterone (DHT), formed through the 5alpha-reductase pathway.
The conversion of dihydrotestosterone (DHT) to 5a-Androstanediol occurs in several tissues, primarily through the action of the enzyme 3-alpha-hydroxysteroid dehydrogenase (3α-HSD).
This process primarily occurs in the testes, epididymis and prostate in men, as well as in the liver, brain, skin, and muscle in both sexes. In women, this process may also occur in the mammary glands and uterus, as these tissues contain different isoforms of the enzyme 3-alpha-hydroxysteroid dehydrogenase. [3., 5.]
The 5-alpha reductase enzyme produces dihydrotestosterone (DHT) from its parent hormone testosterone; DHT is the most potent androgen.
As a metabolite of testosterone via the 5-alpha reductase pathway, 5-alpha-androstanediol describes the level of androgenic activity occurring in an individual. It can also be considered a regulator of androgenic activity, as its effects are not as potent as those of DHT.
Beyond its use as a marker for androgenic activity, 5a-Androstanediol has physiological functions of its own, particularly in the regulation of androgen and estrogen activities within the body.
5a-Androstanediol serves as a key product in the metabolism of more potent androgens, thereby influencing a wide range of physiological functions.
By modulating local levels of dihydrotestosterone (DHT), 5a-Androstanediol helps in regulating the androgenic activity that is critical for sexual development and reproductive function.
This modulation is particularly important in tissues sensitive to androgens such as the prostate, skin, and hair follicles, where it helps to maintain a balance between androgenic stimulation and local tissue health.
Testosterone and its potent metabolite DHT drive dermatological processes such as acne and alopecia, particularly in women.
5a-Androstanediol is produced by the conversion of DHT through the enzyme 3α-hydroxysteroid dehydrogenase (3α-HSD). This conversion reduces the androgenic activity of DHT, which is a more potent androgen.
Acne
Sebum production, which contributes to acne, is accelerated by the conversion of testosterone to DHT. The subsequent conversion of DHT to 5a-Androstanediol by 3α-HSD reduces the androgenic effects.
Increased activity of 5α-reductase and 3α-HSD in patients with acne may lead to higher local androgen concentrations, but the conversion to 5a-Androstanediol can mitigate some effects of DHT.
Alopecia
In androgenetic alopecia (AGA), increased 5α-reductase activity leads to elevated DHT levels in hair follicles. The conversion of DHT to 5a-Androstanediol by 3α-HSD reduces the amount of active DHT, potentially slowing hair follicle miniaturization and hair thinning.
Treatments for such conditions generally focus on reducing the activity of the 5-alpha-reductase enzyme to reduce DHT levels, which will therefore reduce 5a-androstanediol levels as well.
5a-Androstanediol in Innate Immune Function [13.]
5-alpha-androstanediol is important for maintaining innate immunity. It has demonstrated effectiveness in protecting against hematopoietic acute radiation syndrome (ARS) in both murine and non-human primate (NHP) models.
A key protective mechanism of 5a-Androstanediol is its induction of granulocyte colony-stimulating factor (G-CSF), which supports the survival and proliferation of granulocytes essential for combating infections and aiding recovery from radiation-induced damage.
Additionally, 5a-Androstanediol increases the number of circulating neutrophils, platelets, and natural killer (NK) cells, promoting myelopoiesis and enhancing the body's resistance to infections and hematopoietic recovery.
It also reduces radiation-induced apoptosis, helping protect hematopoietic stem cells and other critical immune cells from damage.
Furthermore, 5a-Androstanediol aids in DNA repair and regulates cell cycle progression, reducing radiation-induced DNA damage and enhancing cell survival. Preclinical studies have shown that 5a-Androstanediol protects against radiation-induced damage by enhancing the survival of hematopoietic cells and reducing the severity of cytopenias.
It also stimulates the function of innate immune cells, increasing phagocytic activity in granulocytes and oxidative burst in monocytes.
Clinical trials have demonstrated that 5a-Androstanediol is safe and well-tolerated, effectively increasing neutrophil and platelet counts.
Antioxidant and Anti-Inflammatory Effects of 5a-Androstanediol [16.]
5a-Androstanediol and its derivatives exhibit significant effects on the immune system, particularly by reducing oxidative stress.
In one study, synthesized derivatives of DHEA and 5a-Androstanediol were tested for their cytotoxic and antioxidant properties. [16.] The compounds showed micromolar cytotoxic activity toward cancer cells (HeLa and K562) and demonstrated cytoprotective properties by stimulating the growth of normal Wi-38 cells.
The results indicated that these steroid derivatives reduced reactive oxygen species (ROS) production and may potentially exhibit anti-inflammatory properties.
The presence of 5a-Androstanediol may have significant local impacts, particularly in tissues that express the enzymes necessary for its conversion from DHT.
In the prostate, its role in modulating DHT levels makes it a molecule of interest in the study of benign prostatic hyperplasia (BPH) and prostate cancer. In prostate tissue, DHT drives the activation of the androgen receptor (AR) and promotes tumor growth.
Conversion of DHT to the less potent 5a-Androstanediol may reduce the clinical severity of some prostate disease, although alternate pathways of potent androgen production may also be upregulated. [12.]
Blood tests are commonly used to assess levels of 5a-androstanediol levels, typically for endocrine or specialized studies.
Urine samples are also often used for 5a-Androstanediol testing, especially in functional medicine settings.
Androgen metabolites can be excreted in the urine, making it a reliable method for testing androgen processing and comparing ratios of androgenic metabolites. Urine testing can aid in understanding an individual’s biochemical preference for the 5-alpha pathway of androgen processing, which produces the more potent DHT, or for the 5-beta pathway, which produces less potent androgenic effects.
Urine collection can be easier and less stressful for patients compared to blood draws, as samples can be collected at home without the need for a clinical setting. Additionally, urinary levels can reflect longer-term hormone exposure rather than the transient levels often seen in blood, as it reflects detoxification patterns (rather than providing snapshots of levels in the bloodstream).
It is important to consult with the lab company providing testing for their recommended 5a-Androstanediol levels. For reference, one lab provides the following reference range for urine 5a-Androstanediol levels: [11.]
Female: 6-30 ng/mg
Male: 30-250 ng/mg
Hormones never act alone, and their effects are nuanced. Optimal levels of 5a-Androstanediol in urine tests vary depending on individual health conditions, gender, and age. Levels should be interpreted within the context of an individual’s health status, and with assessment of other hormone levels.
Health professionals often recommend that people remain within the reference range of 30-250 ng/mg for men, and 6-30 ng/mg for women in urine samples, to maintain optimal hormone levels without experiencing hormone excess or deficiency.
However, a professional's recommendation will be affected by many factors including the patient’s overall health, detoxification capacity, personal and family health history, time of life, diet and lifestyle, medications, and other factors.
Regular monitoring through urinary tests is essential to ensure that estrogen metabolite levels are within a safe range, thereby reducing the potential for DNA damage and promoting better hormonal balance and overall health.
In postmenopausal women receiving hormone replacement therapy, elevated levels of 5a-Androstanediol may indicate an excessive amount of hormone supplementation which may be causing unwanted overstimulation of hormone-sensitive tissue.
These women should have their dosages assessed by a healthcare professional, and hormone detoxification support may be considered.
Premenopausal women with elevated levels of 5a-Androstanediol should be assessed by a healthcare professional, including a comprehensive assessment of male and female sex hormones, as well as considering adrenal and thyroid hormone levels.
Additionally, assessment for cardiometabolic markers including blood sugar assessment should be considered if concern for PCOS is present.
Premenopausal women or women supplementing with testosterone who complain of testosterone excess symptoms should be assessed for testosterone and testosterone metabolite levels.
See below for more information on natural methods to promote hormone balance.
Typically, declining levels of testosterone and its metabolites are seen with increasing age. Testing of androgen metabolites may be recommended for women complaining of symptoms associated with decreasing hormone levels.
Testing for DHT levels in conjunction with 5a-Androstanediol is crucial because 5a-Androstanediol is a metabolite of DHT, formed by the action of 3alpha-hydroxysteroid dehydrogenase enzymes.
Measuring both DHT and 5a-Androstanediol levels can help assess the activity of this metabolic pathway and its potential impact on androgen-sensitive tissues. This co-testing is especially important for individuals concerned about prostate health.
Evaluating these markers together can provide valuable information for understanding androgen-related conditions in the prostate and other tissues.
Testosterone is the precursor for the formation of DHT, which is then metabolized to 5a-Androstanediol. Evaluating testosterone levels along with its downstream metabolites, such as DHT and 5a-Androstanediol, provides insights into the overall androgen biosynthesis and metabolism.
This comprehensive assessment can help identify potential dysregulations in androgen production and metabolism that may contribute to altered 5a-Androstanediol levels and associated physiological effects.
DHEA (dehydroepiandrosterone) is a precursor for the synthesis of both testosterone and DHT. Measuring DHEA levels in conjunction with 5a-Androstanediol can help identify potential upstream dysregulations in androgen production that may contribute to altered 5a-Androstanediol levels.
Evaluating DHEA levels along with downstream markers like 5a-Androstanediol can provide insights into imbalances in androgen metabolism pathways and their potential consequences.
It is always essential to work with a qualified healthcare professional in any case of hormone imbalance. The following diet and lifestyle measures have been shown to naturally promote healthy hormone balance:
Dietary Fiber Increase: consuming more fiber helps bind estrogen in the digestive tract, promoting its excretion and reducing reabsorption. [6.]
Interestingly, one study of 240 women also showed a correlation between increased fiber intake and anovulation, possibly due to lower estrogen levels. [6.]
Cruciferous Vegetables: foods like broccoli, cauliflower, and Brussels sprouts contain indole-3-carbinol, which aids in detoxifying excessive estrogen and optimizing hormone balance. [2.]
Regular Exercise: physical activity can help balance hormones by improving metabolism and reducing fat, which is significant since body fat can produce and store estrogen. [15.]
Probiotics and Gut Health: a healthy gut flora supports proper digestion and detoxification processes, including the breakdown, elimination and balance of hormones like estrogen. [9.]
Limit Alcohol and Caffeine: reducing intake of substances that can impair liver function helps ensure the liver effectively processes and removes excess hormones. [4., 14.]
Stress Management: stress may have an impact on estrogen levels and metabolism; techniques such as yoga, meditation, or even simple breathing exercises can reduce cortisol levels and help maintain a healthy hormonal balance. [1.]
Click here to compare testing options and order tests for 5a-androstanediol levels.
[1.] Assad S, Khan HH, Ghazanfar H, Khan ZH, Mansoor S, Rahman MA, Khan GH, Zafar B, Tariq U, Malik SA. Role of Sex Hormone Levels and Psychological Stress in the Pathogenesis of Autoimmune Diseases. Cureus. 2017 Jun 5;9(6):e1315. doi: 10.7759/cureus.1315. PMID: 28690949; PMCID: PMC5498122.
[2.] Auborn KJ, Fan S, Rosen EM, et al. Indole-3-Carbinol Is a Negative Regulator of Estrogen. The Journal of Nutrition. 2003;133(7):2470S2475S. doi:https://doi.org/10.1093/jn/133.7.2470s
[3.] Chapman, J.C., Michael, S.D. Proposed mechanism for sperm chromatin condensation/decondensation in the male rat. Reprod Biol Endocrinol 1, 20 (2003). https://doi.org/10.1186/1477-7827-1-20
[4.] Emanuele MA, Wezeman F, Emanuele NV. Alcohol's effects on female reproductive function. Alcohol Res Health. 2002;26(4):274-81. PMID: 12875037; PMCID: PMC6676690.
[5.] Escamilla-Cruz M, Magaña M, Escandón-Perez S, Bello-Chavolla OY. Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review. Dermatol Ther (Heidelb). 2023 Aug;13(8):1721-1731. doi: 10.1007/s13555-023-00974-4. Epub 2023 Jul 11. PMID: 37432644; PMCID: PMC10366043.
[6.] Gaskins AJ, Mumford SL, Zhang C, et al. Effect of daily fiber intake on reproductive function: the BioCycle Study. The American Journal of Clinical Nutrition. 2009;90(4):1061-1069. doi:https://doi.org/10.3945/ajcn.2009.27990
[7.] Handa RJ, Weiser MJ, Zuloaga DG. A role for the androgen metabolite, 5alpha-androstane-3beta,17beta-diol, in modulating oestrogen receptor beta-mediated regulation of hormonal stress reactivity. J Neuroendocrinol. 2009 Mar;21(4):351-8. doi: 10.1111/j.1365-2826.2009.01840.x. PMID: 19207807; PMCID: PMC2727750.
[8.] Human Metabolome Database: Showing metabocard for 5alpha-Androstane-3beta,17beta-diol (HMDB0000493). hmdb.ca. Accessed May 15, 2024. https://hmdb.ca/metabolites/HMDB0000493
[9.] Maeng LY, Beumer A. Never fear, the gut bacteria are here: Estrogen and gut microbiome-brain axis interactions in fear extinction. International Journal of Psychophysiology. 2023;189:66-75. doi:https://doi.org/10.1016/j.ijpsycho.2023.05.350
[10.] Marchetti PM, Barth JH. Clinical biochemistry of dihydrotestosterone. Annals of Clinical Biochemistry. 2013;50(2):95-107. doi:https://doi.org/10.1258/acb.2012.012159
[11.] Rupa Health. 1.DUTCH Complete M+F Sample Report.pdf. Google Docs. https://drive.google.com/file/d/1-qmxwjo6B2TVYlgCS-FlcyF8FuqRdZEe/view
[12.] Sharifi N. The 5α-androstanedione pathway to dihydrotestosterone in castration-resistant prostate cancer. J Investig Med. 2012 Feb;60(2):504-7. doi: 10.2310/JIM.0b013e31823874a4. PMID: 22064602; PMCID: PMC3262939.
[13.] Singh VK, Seed TM. The potential value of 5-androstenediol in countering acute radiation syndrome. Drug Discov Today. 2024 Feb;29(2):103856. doi: 10.1016/j.drudis.2023.103856. Epub 2023 Dec 13. PMID: 38097137.
[14.] Sisti JS, Hankinson SE, Caporaso NE, Gu F, Tamimi RM, Rosner B, Xu X, Ziegler R, Eliassen AH. Caffeine, coffee, and tea intake and urinary estrogens and estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1174-83. doi: 10.1158/1055-9965.EPI-15-0246. Epub 2015 Jun 10. PMID: 26063478; PMCID: PMC4526325.
[15.] Smith AJ, Phipps WR, Thomas W, Schmitz KH, Kurzer MS. The effects of aerobic exercise on estrogen metabolism in healthy premenopausal women. Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):756-64. doi: 10.1158/1055-9965.EPI-12-1325. PMID: 23652373; PMCID: PMC3648856.
[16.] Sokolov MN, Rozhkov VV, Uspenskaya ME, et al. The Effects of the Steroids 5-Androstenediol and Dehydroepiandrosterone and Their Synthetic Derivatives on the Viability of K562, HeLa, and Wi-38 Cells and the Luminol-Stimulated Chemiluminescence of Peripheral Blood Mononuclear Cells from Healthy Volunteers. Biomolecules. 2024;14(3):373-373. doi:https://doi.org/10.3390/biom14030373
[17.] Sumińska M, Bogusz-Górna K, Wegner D, Fichna M. Non-Classic Disorder of Adrenal Steroidogenesis and Clinical Dilemmas in 21-Hydroxylase Deficiency Combined with Backdoor Androgen Pathway. Mini-Review and Case Report. Int J Mol Sci. 2020 Jun 29;21(13):4622. doi: 10.3390/ijms21134622. PMID: 32610579; PMCID: PMC7369945.